WHO ICTRP trial
Efficacy of zoledronic acid 5 mg for chronic low back pain due to Modic changes
EUCTR2008-005351-14-FI · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-005351-14-FI |
|---|---|
| Public title | Efficacy of zoledronic acid 5 mg for chronic low back pain due to Modic changes |
| Scientific title | Efficacy of zoledronic acid 5 mg for chronic low back pain due to Modic changes |
| Primary sponsor | University of Oulu, Department of Physical and Rehabilitation Medicine |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland |
| Conditions | Modic changes are vertebral endplate changes and bone marrow changes visible in magnetic resonance imaging (MRI), which are closely assosiated with disc degeneration. Modic changes are assosiated with low back pain (LBP) both in clinical… |
| Interventions | Trade Name: Aclasta Product Name: Aclasta/zoledronic acid 5 mg Pharmaceutical Form: Intravenous infusion INN or Proposed INN: ZOLEDRONIC ACID CAS Number: 118072938 Pharmaceutical form of the placebo: Intravenous infusion Route of… |
| Registration date | Jan 9, 2008 |
| Secondary IDs | CZOL446HFI03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: